Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-04

Clinical Trial Update: Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update assesses 18F-FLT PET-CT for defining tumor volumes in high-grade gliomas, including astrocytoma and glioblastoma, across Phase 1 and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 18F-FLT PET-CT (fluorothymidine labeled with fluorine-18)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: High-grade Glioma, Astrocytoma | Phase 1, Phase 2 | Status: COMPLETED